Skip to main content

Table 1 (abstract P-079). Summary of key parameters from top-performing supplements

From: Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative Therapies

 

Max Viable

Cell Density

(x 106 cells/mL)

Estimated Cumulative Cell Density

(x 106 cells/mL)

Final Titer

(mg/L)

Percent Galactosylation (%)

Man 5 (%)

CDC EC50

(μg/mL)

Control,

No Supplements

28.2

198

1850

15.8

6.6

1.71

Optimized Supplement

25.7

185

1538

44.5

7.5

1.19

2X Supplier 1 Supplement

21.1

148

1964

40.2

12.8

1.62